Clinical Trials Sponsored by Triangel Scientific

Total 2012 results

S.LAB (SOLOWAYS)
Center of New Medical Technologies; Triangel Scientific

Completed

Effectiveness and Safety of Semaglutide Combined With Dietary Fiber (Soloways) in Adults With Overweight or Obesity (ESSENCE)

Overweight and Obesity

Russian Federation
S.LAB (SOLOWAYS)
Center of New Medical Technologies; Triangel Scientific

Completed

Evaluating the Impact of B Vitamin Supplementation (Soloways™) on Homocysteine and LDL-C Levels in Patients With MTHFR, MTR, and MTRR Polymorphisms. (VITAGEN-H)

Hyperlipoproteinemias | Hyperhomocysteinemia

Russian Federation
S.LAB (SOLOWAYS)
Center of New Medical Technologies; Triangel Scientific

Completed

Evaluating the Impact of Omega-3 Fatty Acid Supplementation (Soloways™) on Lipid Profiles in Adults With PPARG Polymorphisms (SOLIPARG)

LDL Hyperlipoproteinemia | Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia | Triglyceride Storage Type I or II Disease

Russian Federation
S.LAB (SOLOWAYS)
Center of New Medical Technologies; Triangel Scientific

Completed

Preventing Weight Regain Post-Semaglutide Treatment With Active Fiber Supplement (Soloways) (PWR-FAST)

Overweight and Obesity

Russian Federation
S.LAB (SOLOWAYS)
Center of New Medical Technologies; Triangel Scientific

Completed

Efficacy of Dietary Fiber Supplementation (Soloways) in Patients With Specific Genetic Polymorphisms (SOLFIBERGP)

Obesity

Russian Federation
Triangle Pharmaceuticals

Unknown

A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.

Hepatitis B

United States, Canada, China, France, Singapore
Bristol-Myers Squibb
Boehringer Ingelheim; Triangle Pharmaceuticals

Terminated

The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors

HIV Infections

United States
Universidade Federal do Triangulo Mineiro

Recruiting

Integrative and Complementary Health Practices (PICS) (PICS)

Neoplasms | Epilepsy

Brazil
Universidade Federal do Triangulo Mineiro

Unknown

Effect of Resistance Training Variable Manipulation in Postmenopausal Breast Cancer Survivors.

Postmenopause | Breast Cancer Survivors

Brazil
Universidade Federal do Triangulo Mineiro

Unknown

Fatigability and Physical Performance: Effects of Resistance Training Variables Manipulation

Aging

Brazil
Universidade Federal do Triangulo Mineiro

Recruiting

Effects of Laying on of Hands in Fibromyalgia

Fibromyalgia

Brazil
Universidade Federal do Triangulo Mineiro

Recruiting

The Evaluation Complementary Spirit Therapy

Depression | Pain | Stress | Anxiety | Well-being

Brazil
Universidade Federal do Triangulo Mineiro

Completed

Study of Spirit Pass in Newborn and Patient (SSPNP)

Pain | Stress

Brazil
Universidade Federal do Triangulo Mineiro

Completed

Cachexia in Gynecological Cancer and the Preventive Role of Weight Training

Gynecologic Cancer | Physical Activity | Menopause | Breast Cancer Female
Universidade Federal do Triangulo Mineiro

Completed

Dual Task in Institutionalized Elderly

Aging
Universidade Federal do Triangulo Mineiro

Completed

Pilates and Muscle Strength Respiratory

Conditions

Brazil
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates; Triangle Biostatistics

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis

Primary Biliary Cholangitis

United States, Spain, Canada, Australia, United Kingdom, Germany, Netherlands, Belgium, Austria, France
Triangle Pharmaceuticals

Completed

A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-Naive

HIV Infections

United States
Triangle Pharmaceuticals

Completed

A Study of MKC-442 in Combination With Other Anti-HIV Drugs

HIV Infections

United States
Triangle Pharmaceuticals

Suspended

A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

HIV Infections

United States
Triangle Pharmaceuticals

Completed

Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination

HIV Infections

United States
Triangle Pharmaceuticals

Completed

A Study of MKC-442 in HIV-Positive Patients

HIV Infections
Nantes University Hospital
CSAPA Apsyades; OPPELIA-Le triangle

Completed

Treatment for Opiate Addiction: Prognostic fActors of Responsiveness to Maintenance Treatment (TOPAZE)

Opioid-use Disorder

France
Enanta Pharmaceuticals, Inc
ICON Clinical Research; Triangle Biostatistics

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis

Non-Alcoholic Steatohepatitis

United States, United Kingdom, New Zealand, Canada, France, Puerto Rico
Bristol-Myers Squibb
Triangle Pharmaceuticals; Pharmacia and Upjohn

Terminated

The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors

HIV Infections

United States
Triangle Pharmaceuticals

Unknown

Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV

HIV Infections

United States, Argentina, Mexico, Panama, Puerto Rico, South Africa
Triangle Pharmaceuticals

Unknown

A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs

HIV Infections

United States, Puerto Rico, Canada, Argentina, Chile, Mexico
Jenscare Scientific

Not yet recruiting

A Prospective, Multicenter Study to Evaluate the JensClip Transcatheter Valve Repair System

Mitral Valve Regurgitation | Degenerative Mitral Valve Disease
Semler Scientific

Completed

Measuring Cardiovascular Performance and Blood Flow Using Common But Never Compared Methods

D012039 | D001775

United States
Jenscare Scientific

Recruiting

A Study to Evaluate the Safety and Performance of LuX-Valve Plus System for Tricuspid Replacement

Tricuspid Regurgitation

France
Hero Scientific

Recruiting

Detection of Group A β-Hemolytic Streptococci in Oral Samples

Group A β-Hemolytic Streptococci

Israel
Jenscare Scientific

Enrolling by invitation

The JensClip Transcatheter Valve Repair System for Treating Functional Mitral Regurgitation

Functional Mitral Regurgitation

China
Novus Scientific

Completed

Safety and Performance Study of TIGR Matrix Surgical Mesh in Inguinal Hernia Repair

Inguinal Hernia

Sweden
MD Scientific

Terminated

Evaluation of Sodium Bicarbonate to Reduce the Incidence of Contrast Induced Chronic Kidney Injury in Patients With Kidney Disease (BOSS)

Contrast Induced Kidney Injury.

United States
Centers for Disease Control and Prevention
Children's Research Triangle

Completed

Neurocognitive Habilitation for Children With Fetal Alcohol Syndrome (FAS)/Alcohol-Related Neurodevelopmental Disorder (ARND)

Fetal Alcohol Syndrome | Alcohol-related Neurodevelopmental Disorder

United States
Richard E. Ringel

Completed

Coarctation Of the Aorta Stent Trial (COAST)

Coarctation of the Aorta

United States
Lislei Jorge Patrizzi

Completed

Strengthening in Functional Mobility of Active Elderly

Aged | Muscle Strength

Brazil
Circa Scientific, Inc.

Recruiting

Epicardial Access Study With Rook (EASY-R)

Arrythmia

Czechia
Boston Scientific Corporation

Recruiting

VITALYST Early Feasibility Study in High-Risk PCI Patients (VITALYST EFS) (VITALYST EFS)

Heart Disease, Coronary | High-risk Percutaneous Coronary Intervention

United States, Sweden
Boston Scientific Corporation

Recruiting

MANTIS Endoscopic Clipping Study

Endoscopy | Hemostasis | Perforation Colon | Feeding Tube Complication

United States, India, Hong Kong, Canada, Japan, China
Boston Scientific Corporation

Recruiting

Watchman FLX Pro CT Pilot Study

Non-valvular Atrial Fibrillation (AF)

Denmark
Boston Scientific Corporation

Recruiting

A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM (FRONTIER)

Glioblastoma Multiforme | Recurrent Glioblastoma

United States
Boston Scientific Corporation

Recruiting

Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature (ELEGANCE)

Peripheral Vascular Diseases

United States, Australia, Taiwan, Canada, Thailand, Austria, Germany, Spain, France, China, Poland
Boston Scientific Corporation

Recruiting

Radiofrequency (RF) Ablation Prospective Outcomes Study (RAPID)

Pain, Chronic

United States, United Kingdom, Germany, Belgium, Italy, Netherlands
Boston Scientific Corporation

Recruiting

Vercise™ DBS Dystonia Prospective Study

Dystonia

Germany, United Kingdom, Italy, Belgium, Hungary, Israel, Netherlands, Poland, Russian Federation, Spain, Korea, Republic of
Boston Scientific Corporation

Recruiting

RELIEF - A Global Registry to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain (RELIEF)

Pain

United States, Spain, Germany, United Kingdom, Belgium, Colombia, Argentina, Australia, Denmark, Israel, Italy, Japan, Canada, Netherlands, Switzerland, Sweden
Boston Scientific Corporation

Completed

SpaceOAR System RWS in China

Localized T1-T2 Prostate Cancer

China
Boston Scientific Corporation

Active, not recruiting

CHAMPION-AF Clinical Trial (CHAMPION-AF)

Stroke | Atrial Fibrillation | Bleeding

United States, Australia, Denmark, Canada, Israel, United Kingdom, France, Belgium, Netherlands, Japan, Germany, Switzerland, Italy, Poland, Saudi Arabia, Spain
Boston Scientific Corporation

Active, not recruiting

Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation (OPTION)

Atrial Fibrillation

United States, Spain, Denmark, Australia, France, Germany, Italy, Poland, Belgium, Netherlands
Boston Scientific Corporation

Active, not recruiting

A Pilot Study to Assess WATCHMAN FLX™ Implants by Cardiac Computed Tomography, Magnetic Resonance Imaging and Transesophageal Echocardiography: WATCHMAN FLX™ CT

The Focus of the Study is to Reduce the Risk of Stroke and Life-threatening Bleeding Events in Patients With Non-valvular Atrial Fibrillation

Denmark

Clinical Trials Sponsored by Triangel Scientific

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations